BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34655812)

  • 1. Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation.
    Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Autelli R; Novo E; Bocca C; Villano G; Ramavath NN; Younes R; Tusa I; Rovida E; Pontisso P; Bugianesi E; Albano E; Parola M
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):459-482. PubMed ID: 34655812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein.
    Morello E; Sutti S; Foglia B; Novo E; Cannito S; Bocca C; Rajsky M; Bruzzì S; Abate ML; Rosso C; Bozzola C; David E; Bugianesi E; Albano E; Parola M
    Hepatology; 2018 Jun; 67(6):2196-2214. PubMed ID: 29266399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-2α promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells.
    Yan R; Cai H; Zhou X; Bao G; Bai Z; Ge RL
    Front Endocrinol (Lausanne); 2024; 15():1344971. PubMed ID: 38501098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
    Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.
    Cannito S; Turato C; Paternostro C; Biasiolo A; Colombatto S; Cambieri I; Quarta S; Novo E; Morello E; Villano G; Fasolato S; Musso T; David E; Tusa I; Rovida E; Autelli R; Smedile A; Cillo U; Pontisso P; Parola M
    Oncotarget; 2015 Feb; 6(4):2206-21. PubMed ID: 25544768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α.
    Xia J; Chen H; Wang X; Chen W; Lin J; Xu F; Nie Q; Ye C; Zhong B; Zhao M; Yun C; Zeng G; Mao Y; Wen Y; Zhang X; Yan S; Wang X; Sun L; Liu F; Zhong C; Xia P; Jiang C; Rao H; Pang Y
    Nat Commun; 2024 Jun; 15(1):4755. PubMed ID: 38834568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis.
    Jin K; Shi Y; Zhang H; Zhangyuan G; Wang F; Li S; Chen C; Zhang J; Wang H; Zhang W; Sun B
    J Hepatol; 2023 Aug; 79(2):403-416. PubMed ID: 37040844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity.
    Ma X; Zhang H; Xue X; Shah YM
    J Biol Chem; 2017 Oct; 292(41):17046-17056. PubMed ID: 28848049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.
    Yu L; Wang H; Han X; Liu H; Zhu D; Feng W; Wu J; Bi Y
    J Endocrinol; 2020 Jul; 246(1):57-67. PubMed ID: 32369776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway.
    Chen J; Chen J; Huang J; Li Z; Gong Y; Zou B; Liu X; Ding L; Li P; Zhu Z; Zhang B; Guo H; Cai C; Li J
    Aging (Albany NY); 2019 Dec; 11(23):10839-10860. PubMed ID: 31796646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
    Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
    Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
    Cai H; Bai Z; Ge RL
    Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model.
    Padilla J; Osman NM; Bissig-Choisat B; Grimm SL; Qin X; Major AM; Yang L; Lopez-Terrada D; Coarfa C; Li F; Bissig KD; Moore DD; Fu L
    J Hepatol; 2024 Feb; 80(2):282-292. PubMed ID: 37890720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
    Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
    Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.
    Menrad H; Werno C; Schmid T; Copanaki E; Deller T; Dehne N; Brüne B
    Hepatology; 2010 Jun; 51(6):2183-92. PubMed ID: 20513003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte-specific knockout of HIF-2α cannot alleviate carbon tetrachloride-induced liver fibrosis in mice.
    Ye J; Chen J; Li Y; Sun L; Lu H
    PeerJ; 2023; 11():e15191. PubMed ID: 37033734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of hypoxia-inducible factor-2α in neutrophils decreases colitis-associated colon cancer.
    Singhal R; Kotla NK; Solanki S; Huang W; Bell HN; El-Derany MO; Castillo C; Shah YM
    Am J Physiol Gastrointest Liver Physiol; 2024 Jan; 326(1):G53-G66. PubMed ID: 37933447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
    Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
    Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.